Evidence map›Paper›PMID 37353182›Full record

ArticleMagnetic resonance imaging2023

Immune cell identity behind the K

Yanrong Zhang, Olivier Keunen, Anna Golebiewska, Marco Gerosa, Jing Wang, Sara Natasha Ghobadi, Ai Huang, Qingyi Hou, Frezghi G Habte, Ningrui Li and 4 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Magnetic resonance imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 4 countries.

Yanrong ZhangDepartment of Radiology, Neuroradiology Division, Stanford University, CA, USA; Stanford Shared FACS Facility, Stanford University, CA, USA.
Olivier KeunenDepartment of Radiology, Neuroradiology Division, Stanford University, CA, USA; In Vivo Imaging Facility, Quantitative Biology Unit, Luxembourg Institute of Health Transversal Activities, 84 Val Fleuri, L-1526, Luxembourg.
Anna GolebiewskaDepartment of Radiology, Neuroradiology Division, Stanford University, CA, USA; Department of Oncology, Luxembourg Institute of Health, 84, Val Fleuri, L-1526, Luxembourg.
Marco GerosaDepartment of Radiology, Neuroradiology Division, Stanford University, CA, USA; Department of Diagnostic and Public Health, University of Verona, Verona 37135, Italy.
Jing WangDepartment of Radiology, Neuroradiology Division, Stanford University, CA, USA; Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jing-wu Road, Jinan 250021, China.
Sara Natasha GhobadiDepartment of Radiology, Neuroradiology Division, Stanford University, CA, USA.
Ai HuangDepartment of Radiology, Neuroradiology Division, Stanford University, CA, USA; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Qingyi HouDepartment of Radiology, Neuroradiology Division, Stanford University, CA, USA; Nuclear Medicine Department, Guangdong Provincial People's Hospital, Guangzhou 510080, China.
Frezghi G HabteStanford Center for Innovation in In vivo Imaging (SCi3), Stanford University, CA, USA.
Ningrui LiDepartment of Radiology, Stanford University, Stanford, CA, USA.
Gerry GrantDepartment of Neurosurgery, Stanford University School of Medicine, CA 94305, USA.
Ramasamy PaulmuruganMolecular Imaging Program at Stanford (MIPS), Canary Center for Cancer Early Detection, Department of Radiology, Stanford University, CA, USA.
Kevin S LeeDepartments of Neuroscience and Neurosurgery and Center for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, Virginia, USA. Electronic address: ksl3h@virginia.edu.
Max WintermarkDepartment of Neuroradiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: max.wintermark@gmail.com.
Stanford University · USLuxembourg Institute of Health · LUCenter for Innovation · USGuangdong Provincial People's Hospital · CNShandong Provincial Hospital · CNThe University of Texas MD Anderson Cancer Center · USUnion Hospital · CNUniversity of Verona · ITUniversity of Virginia · US

Funding

MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain TumorsR01CA217953 · NCI · STANFORD UNIVERSITY · PI HEIT, JEREMY J · 2017 to 2021
$3.1M
Precise, non-invasive, axon-sparing surgery for the treatment of drug resistant epilepsyR01NS102194 · NINDS · UNIVERSITY OF VIRGINIA · PI LEE, KEVIN SCOTT · 2018 to 2022
$2.1M
NCI NIH HHS R01 CA217953NINDS NIH HHS R01 NS102194
6 · The paper itself

Abstract

Dynamic contrast-enhanced MR imaging (DCE-MRI) can assess the integrity of the blood brain barrier (BBB) and has been used in GBM patients to determine glioma grade, predict prognosis, evaluate treatment response, and differentiate treatment-induced effect from recurrence. The volume transfer constant K

Indexed as

Brain NeoplasmsGlioblastomaGliomaAnimalsContrast MediaMagnetic Resonance ImagingMiceContrast MediaDCE-MRIGlioblastomaImmune cell identityK(trans)TAMs

Identifiers

PMID37353182
PMCPMC10528281
OpenAlexW4381487040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.